Zealand Pharma — September 2024
-
Godmorgen
-
Obesity drug developer BioAge Labs aims up to $640 mln valuation in upsized US IPO https://www.reuters.com/business/healthcare-pharmaceuticals/obesity-drug-developer-bioage-labs-targets-up-640-mln-valuation-upsized-us-ipo-2024-09-25/
-
OVERBLIK: Disse selskaber er shortet på det danske aktiemarked https://proinvestor.com/investornyt/1219405/overblik-disse-selskaber-er-shortet-pa-det-danske-aktiemarked
-
har sat sig fra ca 920 til 815 på kirt tid under lav omsætning -nogen vinkel på den her?
-
enig
-
Novo Nordisk: 20 % ned fra toppen kan have flere årsager https://proinvestor.com/boards/122379
-
Prediction: Eli Lilly Will Dominate the Billion-Dollar Weight Loss Drug Market for This Key Reason https://proinvestor.com/investornyt/1219454/prediction-eli-lilly-will-dominate-the-billion-dollar-weight-loss-drug-market-for-this-key-reason
-
De danske fedmeaktier har de seneste dage været på slankekur(s). Især Novo har været i vælten. Og hvordan kan det så være? Det svar er ikke så ligetil. Ud over fedmesektoren kommer Helge Larsen i denne opdatering ind på Bavarian, som falder på en lille opjustering, og Genmab, hvor han ser på selskabets fremtidsudsigter. Kort video: https://proinvestor.com/boards/122389
-
Is Viking Therapeutics Stock a Buy? https://proinvestor.com/investornyt/1220185/is-viking-therapeutics-stock-a-buy
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind